Duncan Baird
Private Equity Investor bij Gilde Healthcare Partners BV
Oorsprong van het eerstegraads netwerk van Duncan Baird
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Addenda Capital, Inc.
 Addenda Capital, Inc. Investment ManagersFinance Addenda Capital, Inc. is an investment management firm headquartered in Montréal, Quebec, Canada. The firm was founded in 1996 and is a subsidiary of Co-operators Financial Services Ltd., which is owned by The Co-Operators Group Ltd. Addenda Capital provides solutions to its institutional and private high net worth clients.
30
| Subsidiary | Investment Managers | 30 |
Gilde Healthcare Partners BV
 Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.
18
| Subsidiary | Investment Managers | 18 |
Co-Operators Investment Counselling Ltd.
 Co-Operators Investment Counselling Ltd. Investment ManagersFinance Co-operators Investment Counselling Ltd. (CIC) provides discretionary investment advisory services to pension plans, insurance companies, endowment and foundation funds, mutual funds, governments and corporations. They are a wholly owned subsidiary of The Co-operators Group Ltd. The firm's ultimate parent is Industrial Alliance Insurance & Financial Services, Inc. (TSE: IAG)
15
| Extinct | Investment Managers | 15 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Duncan Baird via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Ontario Teachers' Pension Plan Board
 Ontario Teachers' Pension Plan Board Investment ManagersFinance The Ontario Teachers' Pension Plan Board (OTPPB) is the Province of Ontario’s pension fund manager headquartered in Toronto, Canada. Founded in 1990, OTPPB administers a defined benefit pension plan to active and retired teachers in Ontario. The firm manages investment portfolio for the benefit of present and future plan members and their survivors. OTPPB is a signatory to the UN Principles for Responsible Investment (UNPRI). | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Regina | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Rotman School of Management | College/University | Graduate Degree | |
Gilde Investment Management BV
 Gilde Investment Management BV Investment ManagersFinance Gilde Investment Management BV is an Independent Private Equity firm founded in 1982. Gilde Investment Management BV is headquartered in Utrecht. | Investment Managers | Investment Committee Member Private Equity Investor | |
UBS Asset Management (Canada) Inc.
 UBS Asset Management (Canada) Inc. Investment ManagersFinance UBS Asset Management (Canada) Inc. (UBSC) is a Canadian portfolio manager headquartered in Toronto, Ontario. The firm is an indirect wholly-owned subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBSC offers investment strategies and services to a broad range of clients and their investment consultants which includes: corporate, public and Taft-Hartley pension plans, endowments and foundations, insurance companies, and, financial institutions. They also provide dedicated advisory, investment and training solutions for sovereign clients such as governments and central banks. | Investment Managers | Director of Research - Equity Analyst-Equity | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Investment Committee Member | |
Scotia Capital, Inc. (Broker)
 Scotia Capital, Inc. (Broker) Investment Banks/BrokersFinance Scotia Capital, Inc. (Broker) (Scotia Capital-Broker) is the broker-dealer division of Scotia Capital, Inc., a full-service financial services firm headquartered in Toronto, Canada. The firm is owned by The Bank of Nova Scotia (NYSE, TSE: BNS). Scotia Capital-Broker delivers a broad range of electronic trading products such as high-touch, low-latency, market access and a broad algorithmic trading suite for a wide range of clients globally. They publish monthly indexes to help investors track the performance of Canadian Hedge Funds and Alternative Mutual Funds. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
ING Bank of Canada
 ING Bank of Canada Regional BanksFinance ING Bank of Canada provides commercial banking, mortgages and other financial services. The company is operating as ING DIRECT. Its services include banking, insurance and asset management services. The company was founded in April, 1997 and is headquartered in Toronto, Canada. | Regional Banks | Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
| York University | College/University | Masters Business Admin Masters Business Admin | |
The Empire Life Insurance Co. (Investment Portfolio)
 The Empire Life Insurance Co. (Investment Portfolio) Investment ManagersFinance The Empire Life Insurance Co. (Investment Portfolio) (Empire Life-IP) is the investment portfolio division of The Empire Life Insurance Co., a life insurance and financial services company headquartered in Kingston, Ontario. Founded in 1923, the firm offers life insurance, investment products and employee benefits. Empire Life-IP manages the client's investment portfolio. | Investment Managers | Portfolio Manager-Fixed Income | |
| Queen's University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Concordia University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Lakehead | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Western Ontario | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| McMaster University | College/University | Masters Business Admin Graduate Degree | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director of Finance/CFO | |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Medical Specialties | Director/Board Member | |
| Erasmus University Rotterdam | College/University | Graduate Degree | |
| University of Leiden | College/University | Graduate Degree Undergraduate Degree | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
| University of Quebec | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| Université Laval | College/University | Chairman Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Wilfrid Laurier University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| HEC Montréal | College/University | Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Gilde Healthcare Holding BV
 Gilde Healthcare Holding BV Financial ConglomeratesFinance Gilde Healthcare Holding BV is an investment holding Dutch company. The private company is based in Utrecht, NL. and has subsidiaries in Australia, Netherlands, United States and Germany. The CEOs of the company are Edwin William de Graaf, Marc Olivier Perret. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director/Board Member | |
Moximed, Inc.
 Moximed, Inc. Medical SpecialtiesHealth Technology Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA. | Medical Specialties | Director/Board Member | |
Empire Life Investments, Inc.
 Empire Life Investments, Inc. Investment ManagersFinance Empire Life Investments, Inc. is a Canadian mutual fund manager headquartered in Toronto, Ontario. The firm was founded in 2011 and is a wholly owned subsidiary of The Empire Life Insurance Co. Empire Life Investments exclusively manages investment solutions for Canadians. | Investment Managers | Portfolio Manager-Fixed Income | |
| UNIQURE N.V. | Biotechnology | Director/Board Member | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member | |
Calypso Biotech SA
 Calypso Biotech SA Pharmaceuticals: MajorHealth Technology Calypso Biotech SA operates as a innovative biopharmaceutical company for gastrointestinal immunological disorders. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Plan-les-Ouates, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member | |
| PURETECH HEALTH PLC | Biotechnology | Director of Finance/CFO | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Calypso Biotech BV
 Calypso Biotech BV BiotechnologyHealth Technology Calypso Biotech BV operates as immunotherapy biotech company. It develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Amsterdam, the Netherlands. | Biotechnology | Director/Board Member | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Synexa Life Sciences BV
 Synexa Life Sciences BV BiotechnologyHealth Technology Synexa Life Sciences BV is a Dutch company that specializes in Biomarker and Bioanalysis Research Services. The company is based in Leiden, Netherlands. The company has expertise in designing and delivering biomarker strategies for biopharma clients. and has subsidiaries in Finland. The company was founded in 2003 by Justin Devine, Patrick Bouic, Paul O'Riordan. The CEO is Emile Lens. | Biotechnology | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Canada | 22 |
| Nederland | 13 |
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 4 |
| Duitsland | 3 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 19 |
| Finance | 13 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 69 |
| Corporate Officer/Principal | 38 |
| Undergraduate Degree | 35 |
| Portfolio Manager-Fixed Income | 25 |
| Private Equity Investor | 18 |
Sterkste connecties
| Insiders | |
|---|---|
| Edwin de Graaf | 14 |
| Richard Drouin | 14 |
| Janke Dittmer | 13 |
| Michael White | 12 |
| Pieter van der Meer | 12 |
| Pierre Martin | 11 |
| Arthur Franken | 11 |
| Joep Muijrers | 10 |
| Marc Olivier Perret | 10 |
| Jim MacDonald | 8 |
| Richard Beaulieu | 7 |
| Mark Robert Vallee | 7 |
| Todd Kapala | 6 |
| Barbara Betanski | 6 |
| Bruce Lewis Harrop | 6 |
- Beurs
- Insiders
- Duncan Baird
- Bedrijfsconnecties
